STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells.
about
Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinomaMammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growthNeutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor modelSTAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitinationImmunological Evasion in GlioblastomaThe Role of the Transcriptional Regulation of Stromal Cells in Chronic InflammationMethylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathwaysHwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenograftsThe role of STAT3 in autophagyMolecular targets of isothiocyanates in cancer: recent advancesHyperglycaemia exacerbates choroidal neovascularisation in mice via the oxidative stress-induced activation of STAT3 signalling in RPE cellsJSI-124 suppresses invasion and angiogenesis of glioblastoma cells in vitroTyk2 and Stat3 regulate brown adipose tissue differentiation and obesityTCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesisStructurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.STAT3 or USF2 contributes to HIF target gene specificity.Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection.Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development.Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histonesStat3 activation is required for the growth of U87 cell-derived tumours in miceThe SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma.VEGF-A Stimulates STAT3 Activity via Nitrosylation of Myocardin to Regulate the Expression of Vascular Smooth Muscle Cell Differentiation Markers.STAT3, p-STAT3 and HIF-1α are associated with vasculogenic mimicry and impact on survival in gastric adenocarcinomaHypoxia potentiates glioma-mediated immunosuppressionSTAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3.Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells.YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical modelsBenzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3.Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1alpha mediates estrogen receptor-alpha-induced mesenchymal stem cell vascular endothelial growth factor productionDiindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3).Receptor "hijacking" by malignant glioma cells: a tactic for tumor progressionAssociation of pSTAT3-VEGF signaling pathway with peritumoral edema in newly diagnosed glioblastoma: an immunohistochemical study.Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylaseActivation of the AT1R/HIF-1 α /ACE axis mediates angiotensin II-induced VEGF synthesis in mesenchymal stem cells.Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.Hypoxia-inducible factor-1alpha enhances haptoglobin gene expression by improving binding of STAT3 to the promoter.Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
P2860
Q21261248-8190BECE-33E4-4F65-8455-BEC691AEDA06Q24603549-7B14A291-1249-4354-A529-1282C3698528Q24612339-ACF98902-5684-4FDD-9430-9B7255900F9AQ24648131-B13D090A-24C7-42F4-A3F6-A0638EBFB6AFQ26746612-20A991CE-EB7A-4560-BBD8-01D546BB44E9Q26778930-69E13EBC-FD11-4EAF-9A4F-45A3C89DA0D7Q27306870-606154BA-60C9-4FA0-A503-BDAAFC752DBDQ27334603-D44CBB5C-DE3C-47B2-AAA4-6373C012B08CQ28084959-6CD197DD-B128-4D90-9B05-48696E07B87CQ28307527-2F992D0B-4641-401A-B7B1-E200F41CF5B0Q28484492-83AC33D0-8923-4FE3-88CC-24E383656504Q28544728-F6BDAFFC-30CD-474A-A1D0-8C83B3981BE1Q30415923-571732CB-656A-4D74-BBB8-400E0DEF554FQ30908891-B6379ED9-786F-40F5-BAB6-E2E517A5AC75Q31085777-B8CDF5CB-AC93-4B06-953A-394E6411EF27Q31132835-A4822EDE-08E3-4DBE-AB0F-B2D6ED9F1097Q33318975-C588EF90-9980-421F-9A50-82F1883D47A5Q33375711-CF111C54-DEAB-4FB1-9753-A5CED62095EAQ33569829-67486BCD-F586-4F92-ABEB-ECAF34B6A7DBQ33656976-2709B536-18FC-4E9A-9BE2-B6E01AB9ED4EQ33683959-F7B26016-B596-4C34-8773-980ECEA1A88BQ33752963-1ED15DA0-16DA-4983-9535-B76F650D9ED1Q33778255-16E81689-2001-4E04-9A95-49995E7C487EQ33809268-74D4AE69-E3A8-491F-A2A9-9D89136F97B6Q33903747-B57D9C1F-E0D2-4505-9D5B-C1D0FCAC23BCQ33909537-832066A6-559C-4101-8A8D-6094B00C4629Q33945427-8AAF9382-0206-4D2C-8997-E2E08B54B9F1Q33952506-9AD7FA26-D15F-4D22-B049-6758A0C3F405Q34030791-DF420804-8A3C-45D2-8399-DEDB1B2192C7Q34053328-A7DF2712-8105-48A1-A700-B15F6549EDBAQ34089612-5B65DB97-C5E3-4569-9FBE-DFCE133AC623Q34142384-D03821D6-B535-4444-9252-0982ED5DF954Q34313996-CEE138FA-6E33-46F6-B115-6479E4B83968Q34371631-21193ED0-91A3-4EF4-8AE5-F2B0B79AE2AAQ34430188-853D5CFA-0A41-41F0-9E3E-8CAEC599E71FQ34461098-F5A45E05-1EB1-4C6E-8A23-37C7D0A00BBDQ34491398-E497BDDA-3545-4ECF-8CFC-1F5E6A0D1C77Q34684790-63D6740C-65ED-430F-B8D3-187B4FE2EE48Q34987834-D9F5AC12-CF1F-496B-A10C-9C63DA7AC0F5Q34993694-1CD05ABE-47D1-4710-904B-F7EE3A52DFC8
P2860
STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
STAT3 is a potential modulator ...... n human renal carcinoma cells.
@en
type
label
STAT3 is a potential modulator ...... n human renal carcinoma cells.
@en
prefLabel
STAT3 is a potential modulator ...... n human renal carcinoma cells.
@en
P2093
P356
P1433
P1476
STAT3 is a potential modulator ...... n human renal carcinoma cells.
@en
P2093
Doo Hyun Chung
Hyun Gyu Lee
Ik Hyun Cho
Jong-Wan Park
Joo Eun Jung
Jung Weon Lee
Myung-Hee Chung
Sang-Kyu Ye
Seongwon Choi
Sun-Hee Yoon
P304
P356
10.1096/FJ.04-3099FJE
P407
P577
2005-05-26T00:00:00Z